Seatbelts in CAR therapy: How Safe Are CARS?

T-cells genetically redirected with a chimeric antigen receptor (CAR) to recognize tumor antigens and kill tumor cells have been infused in several phase 1 clinical trials with success. Due to safety concerns related to on-target/off-tumor effects or cytokine release syndrome, however, strategies to...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Kentaro Minagawa, Xiaoou Zhou, Shin Mineishi, Antonio Di Stasi
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI AG 2015-05-01
Serie:Pharmaceuticals
Ämnen:
chimeric antigen receptor
suicide gene
safety switch
adoptive immunotherapy
cell therapy
Länkar:http://www.mdpi.com/1424-8247/8/2/230
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk